PG2 Injection 500 mg in Acute Stroke Study (Pass)

PHASE2CompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Acute Stroke
Interventions
DRUG

PG2

"STUDY DRUG DOSAGE:IV infusion of PG2 Injection 500 mg in 500 ml Normal Saline at a rate of 200 mg/hr with infusion started within 3-6 hrs of stroke onset and infusion of a total of 500 mg PG2 Injection in 500 ml Normal Saline or 500 ml Normal Saline will be completed within 2.5\~3.5 hrs. The same dose of PG2 Injection 500 mg will be repeated daily for the subsequent 2 days.~ROUTE OF ADMINISTRATION:Continuous IV infusion via a calibrated infusion pump DURATION FOR EACH PATIENT:90 days"

DRUG

placebo

"STUDY DRUG DOSAGE: IV infusion of Placebo Injection 500 mg in 500 ml Normal Saline at a rate of 200 mg/hr with infusion started within 3-6 hrs of stroke onset and infusion of a total of 500 mg Placebo Injection in 500 ml Normal Saline or 500 ml Normal Saline will be completed within 2.5\~3.5 hrs. The same dose of Placebo Injection 500 mg will be repeated daily for the subsequent 2 days.~ROUTE OF ADMINISTRATION:Continuous IV infusion via a calibrated infusion pump DURATION FOR EACH PATIENT:90 days"

Trial Locations (1)

404

China Medical University Hospital, Taichung

All Listed Sponsors
collaborator

National Taiwan University Hospital

OTHER

collaborator

Shin Kong Wu Ho-Su Memorial Hospital

OTHER

collaborator

Tri-Service General Hospital

OTHER

collaborator

Changhua Christian Hospital

OTHER

collaborator

National Cheng-Kung University Hospital

OTHER

collaborator

Kaohsiung Medical University

OTHER

collaborator

En Chu Kong Hospital

OTHER

collaborator

Kuang Tien General Hospital

OTHER

collaborator

Chung Shan Medical University

OTHER

collaborator

Taipei Veterans General Hospital, Taiwan

OTHER_GOV

collaborator

Kaohsiung Veterans General Hospital.

OTHER

collaborator

Taipei Medical University Shuang Ho Hospital

OTHER

collaborator

Cheng Hsin Rehabilitation Medical Center

OTHER

collaborator

Taipei Medical University WanFang Hospital

OTHER

lead

China Medical University Hospital

OTHER

NCT01603667 - PG2 Injection 500 mg in Acute Stroke Study (Pass) | Biotech Hunter | Biotech Hunter